Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue:    
Products, services, other $ 2,002,365 $ 1,220,591
Costs and expenses:    
Cost of products and services 942,383 582,854
Research and development 1,101,509 1,143,420
Selling and marketing 324,728 649,783
General and administrative 3,818,892 3,430,321
Total operating costs and expenses 6,187,512 5,806,378
Operating loss (4,185,147) (4,585,787)
Other (expense) income:    
Interest expense, net (14,450,241) (8,344,236)
Unrealized (loss) gain on investment in equity securities (457,025) 500,358
Loss on extinguishment of liabilities (1,061,073) (3,575,878)
Total other expense (15,968,339) (11,419,756)
Net loss (20,153,486) (16,005,543)
Deemed dividends on beneficial conversion feature (873,798) (61,180)
Preferred stock dividends (1,658,175) (1,517,987)
Net loss attributable to common shareholders $ (22,685,459) $ (17,584,710)
Net loss per share - basic and diluted $ (3.42) $ (5.32)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 6,636,523 3,304,187